Home » Topics » Regulatory » Patents

Patents
RSS

Novel hEED inhibitors presented by Novartis

Jan. 15, 2018

Medshine Discovery patents beta-lactamase inhibitors

Jan. 15, 2018

X4 Pharmaceuticals divulges new CXCR-4 inhibitors for cancer

Jan. 15, 2018

Novel HIV maturation inhibitors identified at ViiV Healthcare

Jan. 12, 2018

Medchem Partners discovers novel nitric oxide donors

Jan. 12, 2018

New nuclear receptor ROR-gamma antagonists discovered at Fudan University

Jan. 12, 2018

Bristol-Myers Squibb patents lysophosphatidic acid receptor antagonists

Jan. 12, 2018

FronThera US Pharmaceuticals presents novel hemoglobin modifier compounds

Jan. 12, 2018

Merck & Co. presents new histone deacetylase 6 inhibitors

Jan. 11, 2018

Incyte discloses novel PD-1/PD-L1 interaction inhibitors

Jan. 11, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....